Presentations & Publications

Glycoprotein D, a Checkpoint Inhibitor of Early T cell Activation, Improves Immunogenicity and Efficacy of an HPV-16 Vaccine in Preclinical Studies

02/06/2020

Xiang ZQ, et al.

Poster –

ASCO-SITC Clinical Immuno-Oncology Symposium, Poster #71

https://www.viriontx.com/wp-content/uploads/Virion-SITC-2020-HPV-Preclin.pdf
Download